joimax moves into larger premises in Germany, US

NewsGuard 100/100 Score

The medical devices company joimax(R) GmbH is moving into new premises both in Germany and the US. "Growth requires space" had already been the motto of the last company move back in 2005.

The US market has an enormous growth potential. This is why the subsidiary joimax(R) Inc. is moving from Campbell to Irvine, California, one of high-tech industry centers in the United States. To meet the growing requirements of the US market the joimax(R) headquarter in Karlsruhe, Germany is also moving into bigger offices. President and founder Wolfgang Ries states: "This step of expansion was necessary to comply with the growing requirements towards our organisation." "The new premises are a perfect operational basis to be able to cover the growing demand for joimax technologies in the US," explains Chip Stevens, CEO of joimax Inc.

The doubling of the operational areas is also a landmark decision with respect to the ongoing product launches of the company. joimax(R) is preparing the launch of the Shrill(R) in Europe, which will shortly be followed by the US launch. This shaver and drill system for the ablation of bone and soft tissue under endoscopic view will be completed by a new pump system called Versicon(R) and an HD endoscopy system. Following the motto "joimax goes HD" the so-called Camsource(R) HD Twister camera system, new HD flat screen monitors and HD endoscopes will be brought to market.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Introducing CELLER8®: Revolutionising Wellness with PEMF Technology